Thesis (M.S.)--University of Missouri--Columbia, 2004. / "May 2004." Typescript. Vita. Includes bibliographical references (leaves 70-75). Also issued on the Internet.

Thesis (M.S.)--Medical University of Ohio, 2006. / "In partial fulfillment of the requirements for the degree of Master of Science in Biomedical Sciences." Major advisor: Zijian Xie. Includes abstract. Document formatted into pages: iv, 50 p. Title from title page of PDF document. Bibliography: pages 40-49.

Thesis (M.Sc.). / Written for the Dept. of Biochemistry. Title from title page of PDF (viewed 2008/12/09). Includes bibliographical references.

Estudo prospectivo para identificar a presença do papilomavírus humano em gestantes adolescentes por meio da captura híbrida II e correlacionar com colpocitologia oncótica convencional, em base líquida e colposcopia. O grupo constituído por 60 gestantes entre 12 a 18 anos e idade gestacional media de 23 semanas. A captura híbrida II foi positiva em 51,7%. A colpocitocologia oncótica convencional : normal em 90% e anormal em 10%. Os achados citológicos anormais: lesão intraepitelial escamosa de baixo grau em 8,3% e carcinoma invasor em 1,7%. A colpocitologia em base líquida: normal em 90% e anormal em 10%. Os achados citológicos anormais: lesão intraepitelial escamosa de baixo grau em 8,3% e lesão intraepitelial escamosa de alto grau em 1,7%. Os achados colposcópicos normais foram o epitélio escamoso normal em 20%, epitélio glandular em 18,3% e a zona de transformação normal em 40%. A zona de transformação anormal presente em 21,7% / Study delineated to identify human papillomavirus by hybrid capture II in pregnant teenagers and to correlate with conventional, liquid-based Pap test and colposcopic findings. The study group was constituted by 60 pregnant women aged between 12 and 18 years old; mean gestational age was 23 weeks. They were submitted to anamnese, Pap smear, hybrid capture technique and colposcopy. Hybrid capture II of human papillomavirus was positive in 51,7% of the cases. Conventional Pap test was normal in 90% and abnormal in 10% of the cases. Abnormal results: low-grade squamous intraepithelial lesion in 8,3% and Invasor carcinoma in 1,7%. Based-liquid Pap test was normal in 90% and abnormal in 10% of the cases. Abnormal results: 8,3% of low-grade squamous intraepithelial lesion and 1,7% of high-grade squamous intraepithelial lesion. Normal results: 20% of normal squamous epithelium, 18,3%of columnar epithelium and 40% of normal transformation zone. Abnormal transformation zone was seen in 21,7% of the cases

Estudo prospectivo para identificar a presença do papilomavírus humano em gestantes adolescentes por meio da captura híbrida II e correlacionar com colpocitologia oncótica convencional, em base líquida e colposcopia. O grupo constituído por 60 gestantes entre 12 a 18 anos e idade gestacional media de 23 semanas. A captura híbrida II foi positiva em 51,7%. A colpocitocologia oncótica convencional : normal em 90% e anormal em 10%. Os achados citológicos anormais: lesão intraepitelial escamosa de baixo grau em 8,3% e carcinoma invasor em 1,7%. A colpocitologia em base líquida: normal em 90% e anormal em 10%. Os achados citológicos anormais: lesão intraepitelial escamosa de baixo grau em 8,3% e lesão intraepitelial escamosa de alto grau em 1,7%. Os achados colposcópicos normais foram o epitélio escamoso normal em 20%, epitélio glandular em 18,3% e a zona de transformação normal em 40%. A zona de transformação anormal presente em 21,7% / Study delineated to identify human papillomavirus by hybrid capture II in pregnant teenagers and to correlate with conventional, liquid-based Pap test and colposcopic findings. The study group was constituted by 60 pregnant women aged between 12 and 18 years old; mean gestational age was 23 weeks. They were submitted to anamnese, Pap smear, hybrid capture technique and colposcopy. Hybrid capture II of human papillomavirus was positive in 51,7% of the cases. Conventional Pap test was normal in 90% and abnormal in 10% of the cases. Abnormal results: low-grade squamous intraepithelial lesion in 8,3% and Invasor carcinoma in 1,7%. Based-liquid Pap test was normal in 90% and abnormal in 10% of the cases. Abnormal results: 8,3% of low-grade squamous intraepithelial lesion and 1,7% of high-grade squamous intraepithelial lesion. Normal results: 20% of normal squamous epithelium, 18,3%of columnar epithelium and 40% of normal transformation zone. Abnormal transformation zone was seen in 21,7% of the cases

Thesis (M.S.)--University of Missouri--Columbia, 2004. / Typescript. Vita. Includes bibliographical references (leaves 70-75). Also issued on the Internet.

Orientador: Jörg Kobarg / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-19T01:34:02Z (GMT). No. of bitstreams: 1 Santos_MarcosTadeudos_D.pdf: 15943486 bytes, checksum: 39810fdf0ace76e5e8963354bdc460ca (MD5) Previous issue date: 2011 / Resumo: O objetivo deste projeto foi estudar genes ativados em células do estroma da medula óssea, induzidos pela co-cultura com blastos leucêmicos, na tentativa de uma melhor compreensão sobre o crostalk entre estas células no microambiente tumoral. Nós identificamos Stanniocalcina-1 (STC1) como um potencial marcador molecular do microambiente tumoral, uma vez que sua expressão foi aumentada cerca de 7 vezes em células do estroma co-cultivadas com blastos leucêmicos primários. STC1 humana é uma glicoproteína secretada e tem sido descrita participando em diferentes processos fisiológicos, incluindo a angiogênese, hipóxia e principalmente, a carcinogênese. Nós produzimos a proteína recombinante STC1 no sistema baculovírus e também anticorpos monoclonais, usados em um ensaio ELISA, que agora será testado como um novo kit de diagnóstico de leucemia por uma empresa brasileira. Além disso, identificamos novos parceiros de interação para STC1 através do sistema de duplo hibrido em levedura sendo que algumas destas interações foram confirmadas por GST-pull down. A região Nterminal foi identificada como sendo a região responsável pela interação de STC1 com seus parceiros. Estudos de localização sub-celular por microscopia, revelaram uma deposição ubíqua citoplasmática e puntiforme nuclear, lembrando corpúsculos nucleares relacionados a SUMOilação. Embora STC1 interaja com a proteína SUMO1 e tenha uma predição de alta probabilidade para ser SUMOilada, ensaios in vitro e in vivo não conseguiram detectar STC1 SUMOilada. No entanto, observamos que STC1 regula a SUMOilação de forma significativa em três outras proteínas. Essas descobertas sugerem um novo papel para STC1 no ciclo de SUMOilação, agindo como uma SUMO E3 ligase. Observamos também que STC1 possui um receptor na membrana plasmática em linhagem de células leucêmicas K562 e que a incubação de STC1 com outras células leucêmicas parece favorecer a proliferação destas células ao passo que estimula uma maior produção da própria STC1 intracelular em células do estroma. Juntos, todos estes resultados abrem novas pistas promissoras a serem exploradas no futuro, uma vez que todos os resultados mostram ligações interessantes com estudos funcionais anteriores em STC1 / Abstract: The aims of this project is to study upregulated genes on bone marrow stromal cells, induced by the co-culture with leukemic blasts, trying to have a better understand about the crosstalk between these cells in the tumor microenvironment. We identified Stanniocalcin-1 (STC1) as a putative molecular marker for the leukemic microenvironment, once its expression was increased around 7 times in stromal cells co-cultivated with primary leukemic blasts. Human STC1 is a secreted glycoprotein that has been implicated in different physiological process, including angiogenesis, hypoxia and mainly in carcinogenesis. We produced the recombinant protein STC1 in baculovirus system and monoclonal antibodies for an ELISA assay that now will be tested as a new leukemia diagnostic kit by a Brazilian company. Moreover, we identified new interacting protein partners for STC1 by yeast two hybrid system and some of these interactions were confirmed by GST-pull down assays. The N-terminal region was mapped to be the region that mediates the interaction between STC1 and its partners. Microscopic subcellular localization, revealed an ubiquitous cytoplasmic and dot-like nuclear deposition, resembling SUMOylation related nuclear bodies. Although STC1 interacts with SUMO-1 and has a high theoretical prediction score for a SUMOylation site, in vitro and in vivo assays could not detect STC1 SUMOylation. However, we found that STC1 significantly regulates the SUMOylation of three other proteins. These ??ndings suggest a new role for STC1 in SUMOylation cycle, acting as a SUMO E3 ligase. We either observe that STC1 has a plasmatic membrane receptor in K562 leukemic cell lines and the incubation of STC1 with other leukemic cells suggest a increase of proliferation of these cells and stimulates the production of more intracellular STC1 at stromal cells. Together, all of these findings open promising new avenues to be explored in future detailed studies, since they all show interesting connections with previous functional studies on STC1 / Doutorado / Genetica Animal e Evolução / Doutor em Genetica e Biologia Molecular

From the yeast genome completed in 1996 to the 12 Drosophilagenomes published earlier this year; little more than a decade has provided an incredible amount of genomic data. Yet even with this mountain of genetic information the regulatory networks that control gene expression remain relatively undefined. In part, this is due to the enormous amount of non-coding DNA, over 98% of the human genome, which needs to be made sense of. It is also due to the large number of transcription factors, potentially 2,000 such factors in the human genome, which may contribute to any given network directly or indirectly. Certainly, one of the central limitations has been the paucity of transcription factor (TF) specificity data that would aid in the prediction of regulatory targets throughout a genome. The general lack of specificity data has hindered the prediction of regulatory targets for individual TFs as well as groups of factors that function within a common regulatory pathway. A large collection of factor specificities would allow for the combinatorial prediction of regulatory targets that considers all factors actively expressed in a given cell, under a given condition. Herein we describe substantial improvements to a previous bacterial one-hybrid system with increased sensitivity and dynamic range that make it amenable for the high-throughput analysis of sequence-specific TFs. Currently we have characterized 108 (14.3%) of the predicted TFs in Drosophilathat fall into a broad range of DNA-binding domain families, demonstrating the feasibility of characterizing a large number of TFs using this technology. To fully exploit our large database of binding specificities, we have created a GBrowse-based search tool that allows an end-user to examine the overrepresentation of binding sites for any number of individual factors as well as combinations of these factors in up to six Drosophila genomes (veda.cs.uiuc.edu/cgi-bin/gbrowse/gbrowse/Dmel4). We have used this tool to demonstrate that a collection of factor specificities within a common pathway will successfully predict previously validated cis-regulatory modules within a genome. Furthermore, within our database we provide a complete catalog of DNA-binding specificities for all 84 homeodomains in Drosophila. This catalog enabled us to propose and test a detailed set of recognition rules for homeodomains and use this information to predict the specificities of the majority of homeodomains in the human genome.